글로벌 암호코코시스 시장 - 산업 동향 및 2028년까지의 예측

시장 분석 및 통찰력 : 글로벌 암호코코시스 시장

암호코코시스 시장은 2021-2028년 예측 기간에 시장 성장을 이룰 것으로 예상됩니다. Data Bridge Market Research는 위에 언급된 예측 기간에 4.70%의 CAGR로 성장할 것으로 예측하여 시장을 분석합니다.

Cryptococcosis는 진균 cryptococcus neoformans와 Cryptococcus gattii에 의해 발생하는 감염성 질환입니다. 이들은 주로 비둘기 똥이 풍부한 토양에서 발견됩니다. 진균을 흡입하여 퍼지고 폐 감염을 초래하여 뇌로 퍼져 수막뇌염을 일으킵니다. 이 질병의 증상은 혼란, 발열, 두통 , 흐릿한 시야, 샘 부기, 체중 감소, 호흡 곤란, 흉통, 피로, 목 경직, 메스꺼움 및 구토입니다.

암호코코균 감염 유병률 증가, 파타 진균 감염 발생률 증가 , 의료비 지출 증가, 제네릭 의약품과 일반 의약품(OTC)의 가용성 증가, 정부 자금 지원 증가, 암호코코균증의 효율적 치료에 대한 소매 약국의 수요 증가는 암호코코균증 시장을 확대할 요인입니다.

약물 개발과 진화하는 임상 시험 생태계, 그리고 정부, 민간 기관, 의료 서비스 제공업체의 증가하는 이니셔티브는 2021~2028년 예측 기간 동안 암호코쿠스증 시장에 유익한 기회를 제공할 것입니다.

그러나 높은 치료 비용과 환자의 제한된 임상적 인식은 시장 성장을 방해하는 요인입니다. 또한 암호코코시스 감염 환자의 사망률 증가로 인한 검사 및 진단 범위 감소와 숙련된 기술자 부족은 위에서 언급한 예측 기간 동안 암호코코시스 시장에 도전이 될 것입니다.

This cryptococcosis market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the cryptococcosis market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Global Cryptococcosis Market Scope and Market Size

The cryptococcosis market is segmented on the basis of treatment, diagnosis, end-users and distribution channel. The growth amongst these segments will help you analyze meager growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.

• On the basis of treatment, the cryptococcosis market is segmented into amphotericin B, flucytosine, fluconazole, voriconazole, surgery treatment and others.
• On the basis of diagnosis, the cryptococcosis market is segmented into bronchoscopy, X-ray, MRI, lung biopsy, CSF polymerase chain reaction (PCR), CT scan and others.
• On the basis of end-users, the cryptococcosis market is segmented into clinic, hospital and others.

The cryptococcosis market is also segmented on the basis of distribution channel into hospital pharmacy, retail pharmacy and online pharmacy.

Cryptococcosis Market Country Level Analysis

Cryptococcosis market is analyzed and market size information is provided by the country, treatment, diagnosis, end-users and distribution channel as referenced above.

The countries covered in the cryptococcosis market report are the U.S., Canada, Mexico, Brazil, Argentina, Peru, Rest of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa.

North America dominates the cryptococcosis market due to the presence of major key players, recent advances in cryptococcosis diagnostics with biomarker test, reimbursement for disease screening, improved access to antifungal drugs and well-developed healthcare sector in this region. Asia-Pacific is expected to grow during the forecast period of 2021-2028 due to the increasing research and development activities, increasing prevalence of cryptococcosis disease, rising investment in the healthcare sector and growing government initiatives.

The country section of the report also provides individual market impacting factors and changes in regulations in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, disease epidemiology and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.

Patient Epidemiology Analysis

Cryptococcosis market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analysis of epidemiology to market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.

Competitive Landscape and Global Cryptococcosis Market Share Analysis

Cryptococcosis market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, company strengths and weaknesses, product launch, clinical trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the companies’ focus related to cryptococcosis market research.

암호포자충증 시장 보고서에 포함된 주요 기업으로는 Johnson & Johnson Private Limited, Bristol-Myers Squibb Company, Novartis AG, Pfizer Inc., Abbott, Glenmark Pharmaceuticals Limited, Bausch Health Companies Inc., Sigmapharm Laboratories, LLC., Astellas Pharma Inc., MATINAS BIOPHARMA HOLDINGS, INC., NuCare Pharmaceuticals, Inc., Teva Pharmaceutical Industries Ltd., Sumitomo Dainippon Pharma Co., Ltd., Gilead Sciences, Inc., Jolly Healthcare, Bayer AG, GREENSTONE LLC, Citron Pharma, Hexal AG, Lunan Pharmaceutical Group, BM Pharmaceuticals, GlaxoSmithKline plc, Mylan NV, Takeda Pharmaceutical Company Limited, Taj Pharmaceuticals Limited 등이 있으며, 그 외 국내 및 글로벌 기업도 포함됩니다. 시장 점유율 데이터는 글로벌, 북미, 유럽, 아시아 태평양(APAC), 중동 및 아프리카(MEA) 및 남미에 대해 별도로 제공됩니다. DBMR 분석가는 경쟁 우위를 이해하고 각 경쟁자에 대한 경쟁 분석을 별도로 제공합니다.

SKU-66550